2-(5,8-dimethylphenanthridin-5-ium-2-yl)-1,3-benzothiazole chloride
C22H17ClN2S — CID 164616310
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(5,8-dimethylphenanthridin-5-ium-2-yl)-1,3-benzothiazole chloride
2-(5,8-dimethylphenanthridin-5-ium-2-yl)-1,3-benzothiazole chloride (PubChem CID 164616310) has the molecular formula C22H17ClN2S and a molecular weight of 376.91 g/mol. Its IUPAC name is 2-(5,8-dimethylphenanthridin-5-ium-2-yl)-1,3-benzothiazole chloride.
Molecular Properties
| Compound Name | 2-(5,8-dimethylphenanthridin-5-ium-2-yl)-1,3-benzothiazole chloride |
|---|---|
| PubChem CID | 164616310 |
| Molecular Formula | C22H17ClN2S |
| Molecular Weight | 376.91 g/mol |
| Exact Mass | 376.08 |
| IUPAC Name | 2-(5,8-dimethylphenanthridin-5-ium-2-yl)-1,3-benzothiazole chloride |
| SMILES | Cc1ccc2c(c1)c[n+](C)c1ccc(-c3nc4ccccc4s3)cc21.[Cl-] |
| InChI | InChI=1S/C22H17N2S.ClH/c1-14-7-9-17-16(11-14)13-24(2)20-10-8-15(12-18(17)20)22-23-19-5-3-4-6-21(19)25-22;/h3-13H,1-2H3;1H/q+1;/p-1 |
| InChIKey | UARPDVBZDHATEP-UHFFFAOYSA-M |
| XLogP | 2.41 |
| TPSA | 16.77 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 376.91 |
| LogP ≤ 5 | 2.41 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het_pyridiniums_A(39)', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164616310 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.